NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Shares of Seattle-based publicly traded biotech company NanoString ...
Collaboration to unify NanoString’s best-in-class spatial biology platforms with Visiopharm’s AI-driven image analysis capabilities to enable integrated end-to-end workflows for translational research ...
NanoString Technologies, joined by three of its subsidiaries, have filed for protection from creditors under Chapter 11 of the U.S. Bankruptcy Code, blaming the $31 million jury award assessed against ...
Bruker Corp. (NASDAQ:BRKR) said it plans to ask for a stay and appeal a ruling on an injunction that will block the sale of NanoString's GeoMX products in the U.S. “We respectfully disagree with the ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, announced today the launch of the latest assay for ...
SEATTLE, March 27, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced ...
NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Seattle-based publicly traded biotech company NanoString Technologies said in ...
MINNEAPOLIS and SEATTLE, Aug. 6, 2020 /PRNewswire/ -- Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical ...
NanoString Technologies Inc (NASDAQ:NSTG) shares are trading lower after a jury in the U.S. District Court for the District of Delaware reached a unanimous verdict favoring 10x Genomics Inc ...
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Acrobat Genomics, NanoString Technologies, Inc. (NASDAQ:NSTG), and the Illumina Accelerator announced today their collaboration with Stanford Medicine to ...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, commented on the November 17th verdict of a ...